- Home
- MNY vs ANTX Comparison
MNY vs ANTX Comparison
Compare MNY & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- ANTX
- Stock Information
- Founded
- MNY 2014
- ANTX 2017
- Country
- MNY Singapore
- ANTX United States
- Employees
- MNY 286
- ANTX N/A
- Industry
- MNY
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- ANTX Health Care
- Exchange
- MNY Nasdaq
- ANTX Nasdaq
- Market Cap
- MNY 43.9M
- ANTX 33.2M
- IPO Year
- MNY N/A
- ANTX 2022
- Fundamental
- Price
- MNY $1.50
- ANTX $1.10
- Analyst Decision
- MNY Strong Buy
- ANTX Buy
- Analyst Count
- MNY 1
- ANTX 2
- Target Price
- MNY $4.00
- ANTX $2.00
- AVG Volume (30 Days)
- MNY 517.5K
- ANTX 95.4K
- Earning Date
- MNY 06-13-2025
- ANTX 08-12-2025
- Dividend Yield
- MNY N/A
- ANTX N/A
- EPS Growth
- MNY N/A
- ANTX N/A
- EPS
- MNY N/A
- ANTX N/A
- Revenue
- MNY $71,649,746.00
- ANTX N/A
- Revenue This Year
- MNY $16.97
- ANTX N/A
- Revenue Next Year
- MNY $19.35
- ANTX N/A
- P/E Ratio
- MNY N/A
- ANTX N/A
- Revenue Growth
- MNY N/A
- ANTX N/A
- 52 Week Low
- MNY $0.55
- ANTX $0.87
- 52 Week High
- MNY $1.88
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- MNY 75.86
- ANTX 48.42
- Support Level
- MNY $0.99
- ANTX $1.05
- Resistance Level
- MNY $1.10
- ANTX $1.10
- Average True Range (ATR)
- MNY 0.18
- ANTX 0.04
- MACD
- MNY 0.06
- ANTX 0.00
- Stochastic Oscillator
- MNY 68.85
- ANTX 50.00
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.